Impact of Left Atrial Posterior Wall Ablation During Pulsed-Field Ablation for Persistent Atrial Fibrillation

. 2024 May ; 10 (5) : 900-912. [epub] 20240131

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid38430087
Odkazy

PubMed 38430087
DOI 10.1016/j.jacep.2024.01.017
PII: S2405-500X(24)00030-6
Knihovny.cz E-zdroje

BACKGROUND: Pulmonary vein isolation (PVI) alone is insufficient to treat many patients with persistent atrial fibrillation (PersAF). Adjunctive left atrial posterior wall (LAPW) ablation with thermal technologies has revealed lack of efficacy, perhaps limited by the difficulty in achieving lesion durability amid concerns of esophageal injury. OBJECTIVES: This study aims to compare the safety and effectiveness of PVI + LAPW ablation vs PVI in patients with PersAF using pulsed-field ablation (PFA). METHODS: In a retrospective analysis of the MANIFEST-PF (Multi-National Survey on the Methods, Efficacy, and Safety on the Post-approval Clinical Use of Pulsed Field Ablation) registry, we studied consecutive PersAF patients undergoing post-approval treatment with a pentaspline PFA catheter. The primary effectiveness outcome was freedom from any atrial arrhythmia of ≥30 seconds. Safety outcomes included the composite of acute and chronic major adverse events. RESULTS: Of the 547 patients with PersAF who underwent PFA, 131 (24%) received adjunctive LAPW ablation. Compared to PVI-alone, patients receiving adjunctive LAPW ablation were younger (65 vs 67 years of age, P = 0.08), had a lower CHA2DS2-VASc score (2.3 ± 1.6 vs 2.6 ± 1.6, P = 0.08), and were more likely to receive electroanatomical mapping (48.1% vs 39.0%, P = 0.07) and intracardiac echocardiography imaging (46.1% vs 17.1%, P < 0.001). The 1-year Kaplan-Meier estimate for freedom from atrial arrhythmias was not statistically different between groups in the full (PVI + LAPW: 66.4%; 95% CI: 57.6%-74.4% vs PVI: 73.1%; 95% CI: 68.5%-77.2%; P = 0.68) and propensity-matched cohorts (PVI + LAPW: 71.7% vs PVI: 68.5%; P = 0.34). There was also no significant difference in major adverse events between the groups (2.2% vs 1.4%, respectively, P = 0.51). CONCLUSIONS: In patients with PersAF undergoing PFA, as compared to PVI-alone, adjunctive LAPW ablation did not improve freedom from atrial arrhythmia at 12 months.

Asklepios Hospital St Georg Hamburg Germany

Cardiology Department Na Homolce Hospital Homolka Hospital Prague Czech Republic

Cardiology Department Na Homolce Hospital Homolka Hospital Prague Czech Republic; Neuron Medical Brno Czech Republic

Catharina Hospital Eindhoven the Netherlands

Clinic for Electrophysiology Herz und Diabeteszentrum NRW Ruhr University Bochum Bad Oeynhausen Germany

Department for Cardiovascular Diseases University Hospital Center Split Split Croatia

Department of Cardiology and Angiology Medical Center and Faculty of Medicine University of Freiburg Freiburg Germany

Department of Cardiology and Vascular Medicine West German Heart and Vascular Center Essen University Duisburg Essen Duisburg Germany

Department of Cardiology Herlev Gentofte University Hospital Hellerup Denmark

Department of Cardiology Jessa Hospitals Hasselt Belgium

Department of Cardiology Rouen Hospital Rouen France

Department of Cardiology University Hospital Rangueil Toulouse France

Department of Cardiology University Hospital Rangueil Toulouse France; I2MC INSERM UMR 1297 Toulouse France

Department of Cardiology University of Groningen University Medical Center Groningen Groningen the Netherlands

Department of Medicine Witten Herdecke University Witten Germany; Department of Electrophysiology Alfried Krupp Hospital Essen Germany

Division of Cardiology Department of Internal Medicine Medical University of Graz Graz Austria

Heart Center Bad Neustadt Rhoen Clinic Campus Bad Neustadt Bad Neustadt an der Saale Germany

Heart Center University Hospital of Cologne Department for Electrophysiology Cologne Germany

Heart Rhythm Department Clinique Pasteur Toulouse France; Universitair Ziekenhuis VUB Brussels Belgium

Icahn School of Medicine at Mount Sinai New York New York USA

Icahn School of Medicine at Mount Sinai New York New York USA; Cardiology Department Na Homolce Hospital Homolka Hospital Prague Czech Republic

IHU LIRYC CHU Bordeaux University of Bordeaux Pessac France

IKEM Institute for Clinical and Experimental Medicine Prague Czech Republic

Inselspital Bern University Hospital University of Bern Bern Switzerland

MVZ CCB Frankfurt und Main Taunus GbR Frankfurt Germany

University Heart and Vascular Center University Medical Center Hamburg Eppendorf Hamburg Germany

University Heart Center Lübeck Department of Rhythmology University Hospital Schleswig Holstein Lübeck Germany; German Center for Cardiovascular Research Partner Site Hamburg Kiel Lübeck Lübeck Germany

Citace poskytuje Crossref.org

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...